Erika Martinelli

9.1k citations
126 papers · 6.7k · 5 hit papers · h-index 42

Impact in

  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 1%
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Colorectal Cancer Treatments and Studies 52
    • Cancer Treatment and Pharmacology 10
    • HER2/EGFR in Cancer Research 8
    • Lung Cancer Treatments and Mutations 22
    • Gastric Cancer Management and Outcomes 18

Erika Martinelli

122 papers receiving 6.6k citations

Erika Martinelli's Hit Papers

Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 2022 · 211 citations
2110+2+5Years since publication250500750

Peers

Erika Martinelli
Comparison fields: 5 of 122
  • Hepatology 1.2k
  • Oncology 2.7k
  • Cancer Research 1.0k
  • Pathology and Forensic Medicine 791
  • Pulmonary and Respiratory Medicine 1.3k
Replace Christopher Stroh with:
Christopher Stroh Germany
Lila Adnane United States
Debashis Sarker United Kingdom
Vincenzo Catalano Italy
Dean P. Wilkie United States
Mario Scartozzi Italy
Alessandro Rizzo Italy
Jae Kyung Roh South Korea
Jianping Xiong China
Ferry A.L.M. Eskens Netherlands
Erika Martinelli relative to Christopher Stroh Germany Christopher Stroh's profile →
Citations per field
00.5×1.5×2×2.4×
Christopher Stroh · 1×
Citations per year

Countries citing papers authored by Erika Martinelli

Since Specialization
Citations

This map shows the geographic impact of Erika Martinelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Martinelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Martinelli more than expected).

Fields of papers citing papers by Erika Martinelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Martinelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Martinelli. The network helps show where Erika Martinelli may publish in the future.

Co-authors

The 25 scholars most cited alongside Erika Martinelli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erika Martinelli Line = papers co-authored together Erika Martinelli links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hit paper breakdown →
2018827
2 2008465
3
Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
Hit paper breakdown →
2021359
4
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
Hit paper breakdown →
2018253
5
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
Hit paper breakdown →
2022211
6 2018186
7 2020178
8
Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Hit paper breakdown →
2021147
9 2021139
10 2013138
11 2016135
12 2015125
13 2013111
14 2018110
15 2015106
16 2018106
17 2010100
18 2014100
19 200499
20 201797

About Erika Martinelli

Erika Martinelli is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 126 papers that have together received 6.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (52 papers), Lung Cancer Treatments and Mutations (22 papers), Gastric Cancer Management and Outcomes (18 papers), Cancer Treatment and Pharmacology (10 papers), Genetic factors in colorectal cancer (9 papers), Cancer Genomics and Diagnostics (8 papers), HER2/EGFR in Cancer Research (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). The work is most often cited by research in Hepatology (1.2k citations), Oncology (2.7k citations), Cancer Research (1.0k citations), Pathology and Forensic Medicine (791 citations) and Pulmonary and Respiratory Medicine (1.3k citations). Erika Martinelli has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Fortunato Ciardiello, Teresa Troiani, Floriana Morgillo, Andrés Cervantes, Josep Maria Llovet, Jens Ricke, Carminia Maria Della Corte, Chris Verslype, Bruno Sangro and Ian Chau. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, ESMO Open, Oncotarget and Critical Reviews in Oncology/Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact